| Catalog No. | VK565021 |
| Form | Lyophilized |
| Storage buffer | Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. |
| Purity | >90% as determined by SDS-PAGE. |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | Mammalian Cells |
| Accession | P0DTC2 |
| Protein length | Arg319-Phe541 |
| Nature | Recombinant |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Reconstitution | Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details. |
| Alternative name | Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, S, Receptor-Binding Domain, RBD, WT |
| Species | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| Shipping | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| Note | For research use only. |
Recombinant SARS-CoV-2 RBD Protein, C-His
Overview
Images
 SDS-PAGE |
SDS-PAGE for Recombinant SARS-CoV-2 RBD Protein, C-His |
 Bioactivity |
Detects Adintrevimab in indirect ELISAs. |
 Bioactivity |
Detects Amubarvimab in indirect ELISAs. |
 Bioactivity |
Detected by Research Grade Anti-SARS-CoV-2 RBD Antibody (CV30) (Cat No.: VK565013) in indirect ELISA. |
 Bioactivity |
Detected by Research Grade Anti-SARS-CoV-2 RBD antibody (CR3022) (Cat No.: VK565033) in indirect ELISA. |
 Bioactivity |
Detected by Research Grade Casirivimab (Cat No.: VK565046) in indirect ELISA. |
 Bioactivity |
Detected by Research Grade Anti-SARS-CoV-2 RBD antibody (VHH-72-Fc) (Cat No.: VK565053) in indirect ELISA. |
 Bioactivity |
Detected by Research Grade Imdevimab (Cat No.: VK565056) in indirect ELISA. |
 Bioactivity |
Detected by Research Grade Anti-SARS-CoV-2 RBD antibody (EY6A) (Cat No.: VK565063) in indirect ELISA. |
 Bioactivity |
Detected by Research Grade Anti-SARS-CoV-2 RBD antibody (H4) (Cat No.: VK565083) in indirect ELISA. |
 Bioactivity |
Detected by Research Grade Rimteravimab (Cat No.: VK565166) in indirect ELISA. |
 Bioactivity |
Detected by Anti-SARS-CoV-2 NTD antibody (4A8) (Cat No.: VK755013) in indirect ELISA. |